18f-2-fluoro-2-deoxy-d-glucose fluorodeoxyglucose
Trade name: FDG
Small moleculeexperimentalImaging agent
Clinical trial activity
14 trials · 28 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
5
Phase 3
2
Phase 4
0
Earliest trial started Jan 31, 2007 (NCT00634777)
Timeline
Indications
Studied for
- Breast Neoplasms · Early Phase 1
- Breast Neoplasms, Male · Early Phase 1
- Drug-Related Side Effects and Adverse Reactions · Phase 3
- Drugs, Investigational · Phase 3
- Endometriosis · Phase 3
- Esophageal Neoplasms · Phase 1/Phase 2
- Healthy Volunteers · Phase 2
- Neoplasms · Phase 3
- Solitary Pulmonary Nodule · Phase 3
- Stress Disorders, Post-Traumatic · Early Phase 1
- Wounds and Injuries · Early Phase 1
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- 18f-2-fluoro-2-deoxy-d-glucose fluorodeoxyglucose
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07284576 | Phase 2 | Dec 31, 2025 | — |
| NCT07012993 | Phase 2 | May 20, 2025 | — |
| NCT05543590 | N/A | Feb 28, 2023 | Hôpital Européen Marseille |
| NCT05390021 | N/A | Oct 31, 2022 | Harvard University |
| NCT04831619 | Phase 3 | Jun 1, 2021 | Centre Hospitalier Universitaire de la Réunion |
| NCT04615156 | Phase 3 | Nov 1, 2020 | Eastern Health, Canada |
| NCT03295695 | Early Phase 1 (Phase 1) | Oct 31, 2018 | University of South Florida |
| NCT03279393 | Early Phase 1 (Phase 1) | Nov 28, 2017 | Harvard University, Icahn School of Medicine at Mount Sinai, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) |
| NCT03307941 | Phase 1/Phase 2 (Phase 2) | Jul 20, 2017 | Free University of Brussels, Innate Pharma |
| NCT01320852 | N/A | Dec 31, 2010 | McGill University, Pfizer |
| NCT00959166 | N/A | Jun 30, 2009 | Imperial College London |
| NCT00850473 | N/A | Oct 1, 2007 | Washington University in St. Louis |
| NCT00887718 | N/A | Aug 1, 2007 | University of Toronto |
| NCT00634777 | N/A | Jan 31, 2007 | Cliniques universitaires Saint-Luc, Free University of Brussels, Institut Gustave Roussy, Rouen Normandy University, Université catholique de Louvain, University of Liege, University of Lille, University of Lorraine, University of Montpellier, University of Nantes, University of Paris, University of Poitiers, University of Rennes, University of Toulouse |
Showing 14 of 14 trials
Page 1 / 1
Organizations
Research & Development (28)
28 organizations
Page 1 / 2